Abstract
Purpose of Review
The goal of this manuscript is to explain the indications for and applications of fine needle aspiration biopsy for intraocular tumors. By defining the indication of fine needle aspiration biopsy (FNAB), one can plan the timing of the procedure as well as appropriate specimen handling and testing.
Recent Findings
Individualized management of cancer patients based on accurate tumor diagnosis and predictive molecular testing has sparked the interest of clinicians and researchers and is changing the therapeutic approach in ocular oncology in the recent years. This fact has also sparked the interest in standardizing indications and procedures as well as safety of such procedures.
Summary
The definition of indication categories for FNAB has revealed significant differences among FNAB cases performed, their timing, and testing of specimen. Because of that, it appears that reported results of FNABs should explicitly identify the category of the biopsy performed and thus improve the understanding of the procedure and its applications. Also, using standard indications may facilitate analysis and reproducibility of results.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
• Correa ZM, Augsburger JJ. Indications for fine needle aspiration biopsy of posterior segment intraocular tumors. Am J Ophthalmol. 2019;207:45–61 (This manuscript details the current indications of FNAB and their impact on patient demographics, final diagnosis, and biopsy yield).
• Augsburger JJ. Fine·needle aspiration biopsy in the diagnosis of suspected intraocular cancer. In: Jakobiec FAS, J., editor. Advanced techniques in ocular surgery. Philadelphia: WB Saunders; 1984. p. 491–521. (This manuscript dicusses the early techniques used for transvitreal FNAB).
Harbour JW, Chao DL. A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology. 2014;121(6):1281–8.
Onken MD, Worley LA, Char DH, Augsburger JJ, Correa ZM, Nudleman E, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119(8):1596–603.
Eide N, Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review. Acta Ophthalmol. 2009;87(6):588–601.
• Augsburger JJ, Shields JA. Fine needle aspiration biopsy of solid intraocular tumors: indications, instrumentation and techniques. Ophthalmic Surg. 1984;15(1):34–40 (This manuscript discusses early indications for fine needle aspiration biopsy).
• Finn AP, Materin MA, Mruthyunjaya P. Choroidal tumor biopsy: a review of the current state and a glance into future techniques. Retina. 2018;38:S79–87 (This manuscript discussed recent incorporation of vitrectomy-assisted biopsy).
Schefler AC, Gologorsky D, Marr BP, Shields CL, Zeolite I, Abramson DH. Extraocular extension of uveal melanoma after fine-needle aspiration, vitrectomy, and open biopsy. JAMA Ophthalmol. 2013;131(9):1220–4.
Jakobiec FA, Chattock A. The role of cytology and needle biopsies in the diagnosis of ophthalmic tumors and simulating conditions. In: Jakobiec FA, editor. Ocular and adnexal tumors. Birmingham: Aesculapius Publishing Co; 1978. p. 341–58.
Correa ZM. Assessing prognosis in uveal melanoma. Cancer Control. 2016;23(2):93–8.
• Augsburger JJ, Correa ZM, Schneider S, Yassin RS, Robinson-Smith T, Ehya H, et al. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category. Trans Am Ophthalmol Soc. 2002;100:225–32 (discussion 32–4).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Corrêa, Z.M., Augsburger, J.J. Fine Needle Aspiration Biopsy for Intraocular Tumors: Why and When. Curr Ophthalmol Rep 10, 48–52 (2022). https://doi.org/10.1007/s40135-022-00284-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40135-022-00284-6